Dr. Ari Hakimi highlighted how tumor profiling and molecular markers are expanding access to precision-based trials for ...

As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances in diagnosis and treatment.

The six-year study focused on cyproheptadine, the active compound in the antihistamine Periactin. Periactin is commonly ...

A Ludwig Cancer Research study has identified a complex chain of molecular chatter by which cancer cells, exploiting ordinary ...

Immune checkpoint inhibitors (ICIs) are a type of immunotherapy or cancer treatment that targets specific immune cells known ...

A new drug was shown to significantly reduce tumor growth in lab studies by up to 77% for melanoma and colorectal cancers.

Novel multiomics tumor profiling demonstrates feasibility and clinical benefit in guiding melanoma treatment decisions, a ...

People exposed to higher levels of air pollution may be more likely to develop meningioma, a typically noncancerous brain ...

A promising clinical trial shows that a combination of paxalisib, pembrolizumab, and chemotherapy significantly reduces circulating tumor cells in metastatic triple-negative breast cancer.

Bria-IMT plus a checkpoint inhibitor improved survival versus Trodelvy and chemo in patients with heavily pretreated ...

The effects of F. nucleatum, PLA, and CLEC12A on macrophages. GA, UNITED STATES, July 19, 2025 /EINPresswire / -- A growing body of researc ...

In a significant step toward improving targeted cancer therapy, researchers from Japan have developed a novel nanocarrier ...